Table 4 Detection of the CD34 CD38 −... | American Society of Hematology

Table 4

Detection of the CD34⁺CD38⁻ALDH^int population in available follow-up samples of AML patients who achieved morphologic CR

Patient no.	Postinduction/preconsolidation	Time after consolidation						Outcome
Patient no.	Postinduction/preconsolidation	0-6 mo	6-12 mo	12-18 mo	18-24 mo	24-36 mo	36-48 mo	Outcome
1	Absent	Present (0.25%)						Relapsed 34 days after detection
2		Absent	Absent	Absent	Absent			CRp 688 days since diagnosis
3	Absent	Absent						CR 370 days since diagnosis
7		Absent	Present (0.37%)					Relapsed 32 days after detection
10	Absent	Absent						CR 323 days since diagnosis
11		Absent	Absent					CR 691 days since diagnosis
12	Present (0.26%)							Relapsed 25 days after detection
13	Absent	Absent						CR 185 days since diagnosis
14			Present (0.25%)					Relapsed 62 days after detection
15	Present (0.17%)							Relapsed 33 days after detection
16	Present (0.04%)							CR 435 days after allogeneic HSCT
17		Absent	Absent	Absent	Absent	Absent		CRp 810 days since diagnosis
18	Absent	Present (0.03%)						Relapsed 81 days after detection
19						Absent	Absent	CR 1482 days since diagnosis
20		Absent	Absent	Absent				CR 497 days since diagnosis
21						Absent	Absent	CRi 1335 days since diagnosis

Patient no.	Postinduction/preconsolidation	Time after consolidation						Outcome
Patient no.	Postinduction/preconsolidation	0-6 mo	6-12 mo	12-18 mo	18-24 mo	24-36 mo	36-48 mo	Outcome
1	Absent	Present (0.25%)						Relapsed 34 days after detection
2		Absent	Absent	Absent	Absent			CRp 688 days since diagnosis
3	Absent	Absent						CR 370 days since diagnosis
7		Absent	Present (0.37%)					Relapsed 32 days after detection
10	Absent	Absent						CR 323 days since diagnosis
11		Absent	Absent					CR 691 days since diagnosis
12	Present (0.26%)							Relapsed 25 days after detection
13	Absent	Absent						CR 185 days since diagnosis
14			Present (0.25%)					Relapsed 62 days after detection
15	Present (0.17%)							Relapsed 33 days after detection
16	Present (0.04%)							CR 435 days after allogeneic HSCT
17		Absent	Absent	Absent	Absent	Absent		CRp 810 days since diagnosis
18	Absent	Present (0.03%)						Relapsed 81 days after detection
19						Absent	Absent	CR 1482 days since diagnosis
20		Absent	Absent	Absent				CR 497 days since diagnosis
21						Absent	Absent	CRi 1335 days since diagnosis

The percentage of the total mononuclear cells composed of the CD34⁺CD38⁻ALDH^int population (when present) is indicated in parentheses.

CRp indicates CR with incomplete platelet recovery; and CRi, CR with incomplete count recovery.